Company Filing History:
Years Active: 2014
Title: Innovator Jee-Suk Kim: Pioneering Pharmaceutical Advancements
Introduction: Jee-Suk Kim, an accomplished inventor based in Pusan, South Korea, is recognized for his significant contribution to the field of pharmaceuticals. With a focus on innovative compounds and treatments, he has developed a patented solution aimed at addressing a variety of medical conditions.
Latest Patents: Jee-Suk Kim holds one notable patent, which encompasses compounds, isomers thereof, or pharmaceutically acceptable salts characterized as vanilloid receptor antagonists. The title of his patent is "Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same." This invention relates to a pharmaceutical composition devised to prevent or treat diseases such as pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorders, urinary bladder hypersensitivity, irritable bowel syndrome, and respiratory disorders. His innovative work not only offers potential relief for these conditions but also opens new avenues for treatment methodologies in the medical field.
Career Highlights: As part of his professional journey, Jee-Suk Kim is associated with Amorepacific Corporation, a notable entity in the industry. His work within the company underscores his commitment to advancing healthcare through innovative solutions. His patent demonstrates an integration of scientific research with practical application, manifesting in therapies designed to enhance patient well-being.
Collaborations: Throughout his career, Jee-Suk Kim has collaborated with talented professionals, including Byoung Young Woo and Sun-Young Kim. These partnerships highlight the importance of teamwork in the innovation process, as collective expertise fosters the development of groundbreaking ideas and inventions that can significantly impact society.
Conclusion: Jee-Suk Kim's contributions as an inventor reflect his dedication to improving health outcomes through scientific innovation. His patented work in vanilloid receptor antagonists illustrates the profound impact that research and development can have on the treatment of various diseases. As he continues his role at Amorepacific Corporation, the potential for future breakthroughs remains promising, reinforcing his position as a vital figure in the pharmaceutical landscape.